SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Longevity Acquisition Corporation Merger

Wilmington, Delaware, UNITED STATES

WILMINGTON, Del., Dec. 02, 2020 (GLOBE NEWSWIRE) --

Rigrodsky & Long, P.A. announces that it is investigating Longevity Acquisition Corporation (“Longevity”) (NASDAQ GS: LOAC) regarding possible breaches of fiduciary duties and other violations of law related to Longevity’s agreement to merge with 4D Pharma PLC (“4D Pharma”).   Under the terms of the agreement, Longevity’s shareholders will receive 7.5315 ordinary shares of 4D Pharma per share.

To learn more about this investigation and your rights, visit:

You may contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530